Hello, welcome to the 2026 virtual annual meeting of Rapport Therapeutics, Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the annual meeting interface.
Good morning, everyone. My name is Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics Incorporated. The meeting is now called to order. I've asked Jesse Fishman of Goodwin Procter LLP, our outside legal counsel, to record the minutes. It is a pleasure to welcome our stockholders to the annual meeting of Rapport Therapeutics Incorporated. This meeting is being held in accordance with the corporation's bylaws and Delaware law. We will take care of the formal business at hand, which is described in our notice and proxy statement, a copy of which was mailed on or about April 23rd, 2026, to all of our stockholders of record at the close of business on April 14th, 2026. During this meeting, all discussions will be limited to the official business at hand.
Before proceeding to the formal business, I would like to recognize the additional directors of the corporation who are with us today. Present with us in the room are Steve Paul, John Maraganore, Robert Perez, Raymond Sanchez, Paul Silva, and Wendy Young. Participating via teleconference are James Healy and Reid Huber. Thank you. I'd also like to welcome the members of our executive team and representatives from PricewaterhouseCoopers LLP, the corporation's audit firm, and representative from Goodwin Procter LLP. Thank you. Let's proceed to the formal business of the meeting. Notice which was sent to all stockholders of record as of the close of business on April fourteenth, 2026. Stockholders of record on that date are entitled to vote at this meeting. Rules of conduct for the meeting are available in the meeting materials section on the Rapport Broadridge annual meeting page.
Please note that only stockholders who have logged in using their 16-digit control number will be able to vote and ask questions at the meeting. If you have any questions, I encourage you to please submit them now so they can be added to the queue to be answered. If any stockholder wishes to submit a question, please submit your question in writing through the virtual meeting platform using the link provided. In accordance with our rules for conduct at this meeting, only questions and statements relating to the specific agenda items on which stockholders are entitled to vote may be asked. The board of directors has appointed Beth VanDerbeck, an independent inspector of elections designated by Broadridge Financial Solutions, Inc., to act as inspector of elections for this annual meeting, and she will tabulate the voting results.
The inspector of elections has signed the oath of her office, which will be filed with the minutes of this meeting. Ms. VanDerbeck, do we have a quorum present?
Mr. Ceesay, of the 47,807,623 shares of common stock entitled to vote at the meeting, 44,332,911 shares, or 92.73% of shares, are represented either in person or by proxy, and therefore a quorum is present.
I declare that a quorum is present. We may now proceed to transact the business for which this meeting has been called. Let me briefly describe the voting procedures. If you have previously turned in your proxy and you do not intend to change your vote, it is not necessary that you complete another proxy or ballot. Your vote will be counted. If you're eligible to vote and have not submitted your proxy, or if you want to change your vote, you may do so by clicking on the link provided through the virtual meeting platform. In order to allow stockholders to vote through the virtual meeting platform at any time during this meeting, I now declare the polls open for voting. It is now 1:04 P.M. on June 10, 2026. Our first item of business is the election of directors.
At this meeting, we'll be voting on three nominees for Class 2 directors to serve for a term of three years, all as set forth in the proxy statement. In accordance with the bylaws, your directors have nominated James Healy, Robert Perez, and Raymond Sanchez to be elected to serve as Class 2 directors. The corporation's bylaws require that a stockholder provide advance notice to the corporation of a stockholder's intent to nominate persons as directors. No such notice was received. Accordingly, I declare the nominations for directors closed. The board of directors unanimously recommends that stockholders vote in favor of this proposal. The second item of business is the ratification of the appointment of PricewaterhouseCoopers LLP as the corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026.
The audit committee of the board of directors, which is comprised entirely of independent directors, appointed PricewaterhouseCoopers as the corporation's independent registered public accounting firm to audit the corporation's financial statements for the fiscal year ending December 31st, 2026. The board of directors approved the selection of PricewaterhouseCoopers and has asked the stockholders to ratify the selection. Stockholder ratification is not required by the corporation's bylaws. The board of directors is submitting this to the stockholder for ratification as a matter of good corporate governance. If the stockholders do not approve the selection of PricewaterhouseCoopers as the corporation's independent registered public accounting firm, the board of directors and the audit committee will reconsider the appointment. We will now pause to address any questions concerning the matter to be voted upon.
I have no questions.
We have not received any questions, we will move on to the voting. Anyone who has not yet voted and desires to do so, please do so now through the virtual meeting platform. It is now 1:06 P.M. on June 10th, 2026, and the polls for each matter to be voted on at this meeting are now closed. No additional ballots, proxies, or votes, and no changes of revocations will be accepted. Inspector of elections, please report on the results of the voting.
Mr. Chairman, with regard to Proposal 1, a plurality of the shares present or represented and entitled to vote has been voted in favor of the election of the persons nominated. With regard to Proposal 2, a majority of the votes properly cast have been voted in favor of the ratification of PricewaterhouseCoopers as the corporation's independent registered accounting firm for the fiscal year ending December 31, 2026.
Thank you, Ms. VanDerbeck. I declare that all of the proposals presented at the meeting have been ratified or approved by the stockholders. The final results of voting, including any ballots and proxies recorded during this meeting, will be set forth in the report of the inspector of elections and will be included in the minutes of the meeting. The final results will also be included in our reports filed with the SEC. There being no other matters for consideration at this meeting, I hereby adjourn this meeting.
This concludes today's meeting. Thank you for attending. You may now disconnect and have a wonderful rest of your day.